期刊文献+

齐拉西酮治疗精神分裂症的临床研究

下载PDF
导出
摘要 目的探讨齐拉西酮治疗精神分裂症的临床效果。方法选择80例精神分裂症患者,随机分为治疗组和对照组,治疗组用齐拉西酮治疗,对照组用利培酮治疗,比较两组疗效和不良反应。结果治疗组总有效率为85%,对照组为82.5%,2组差异并无统计学意义(P>0.05);治疗组不良反应发生率为25%,对照组为32.5%,2组不良反应发生率总体上比较差异并无统计学意义((P>0.05),但对照组内分泌改变发生率显著高于治疗组(P<0.05)。结论齐拉西酮治疗精神分裂症效果显著,而且不良反应少,患者依从性好,值得在临床推广应用。
作者 彭亮
机构地区 武汉市汉口医院
出处 《中外医疗》 2010年第21期125-125,共1页 China & Foreign Medical Treatment
  • 相关文献

参考文献3

  • 1中华医学会精神科分会.中国精神障碍分类与诊断标准[M].第3版.济南:山东科学技术出版社,2001:87.
  • 2李华芳,谢世平,李鸣,张明廉,李静,苏炳华,顾牛范.齐拉西酮治疗精神分裂症的随机、双盲、双模拟、多中心研究[J].中国新药与临床杂志,2006,25(10):747-752. 被引量:69
  • 3Olie JP,Spina E,Murray S,et al.Ziprasidone and amisulpride effectively treat negativeiisymptoms of schizophrenia results of a 12- week,double-blind study[J].Int Clin Psychophar Macol,2006,21 (3):143- 151.

二级参考文献12

  • 1STAHI SM, SHAYEGAN DK. The psychopharmacology of ziprasidone: receptor-binding propreties and real-world psychiatric practice[J]. J Clin Psychiatry, 2003,64 Suppl 19 : 6-12.
  • 2CALEY CF, COOPER CK. Ziprasidone: the fifth atypical antipsychotie[J]. Ann Pharmaeother. 2002, 36(5 ) : 839-851.
  • 3KANE JM. Oral ziprasidone in the treatment of schizophrenia: a review of short-term trials[J]. J Clin Psychiatry, 2003, 64 Suppl 19:19-25.
  • 4HARVEY PD, SIU CO, ROMANO S. Randomized, controlled,double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder[J]. Psychopharmacology, 2004, 172(3) :324-332.
  • 5HIRSCH SR, KISSLING W, BAUML J, et al. A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia[J]. J Clin Psychiatry, 2002, 63 (6) : 516-523.
  • 6NEMEROFF CB, LIEBERMAN JA, WEIDEN PJ, et al. From clinical research to clinical practive: a d-year review of ziprasidone[J]. CNS Spectr, 2005, 10( 11 ) :s1-s20.
  • 7POTKIN SG, KECK PE Jr, SEGAL S, et al. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebocontrolled replication trial[J]. J Clin Psyehopharmacol, 2005,25(4) :301-310.
  • 8KANE JM, KHANNA S, RAIADHYAKSHA S, et al. Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophrenia[J]. Int Clin Psychopharmacol, 2006, 21 ( 1 ) :21-28.
  • 9SIMPSON GM, GLICK ID, WEIDEN PJ, et al. Randomized,controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder[J]. Am J Psychiatry, 2004, 161 (10) : 1837-1847.
  • 10OLIE JP, SPINA E, MURRAY S, et al. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: resuits of a 12-week, double-blind study[J]. Int Clin Psychopharmacol, 2006, 21(3):143-151.

共引文献254

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部